Applied Clinical Trials Features Marina Acosta Enslen’s Thoughts on Covid-19 Forcing Companies to Comply with the New E6 (R2) Guidelines

​In the December issue of Applied Clinical Trials, Marina Acosta Enslen weighs in on how COVID-19 has forced compliancy within organizations following the implementation of E6 (R2). Read the full article here (page 24).